mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.01 |